logo

For the Inventor, By the Inventor

Copenhagen, Denmark

Philip E Hansen

This inventor holds 10 USPTO granted patents and 1 published patent application. Top assignees: Novo Nordisk A/s, Novo Industri A/s, Rigshospitalet. Active years: 1986-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip E Hansen. Retrieved from https://idiyas.com/inventor/philip-e-hansen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 60.0

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 475(Granted Patents)


Location History:

  • Copenhagen, DK (1986 - 1993)
  • Holte, DK (1999 - 2016)

Company Filing History:

goldMedal8 out of 1,802 
 
Novo Nordisk A/s
 patents
silverMedal1 out of 103 
 
Novo Industri A/s
 patents
bronzeMedal1 out of 19 
 
Rigshospitalet
 patents

Years Active: 1986-2016

Loading Chart...
10 patents (USPTO):Explore Patents
1. 9433589 - Injectable pharmaceutical compositions comprising adrenaline and citric acid (2016-09-06),
2. 8518430 - Dry mouldable drug formulation (2013-08-27),
3. 8084053 - Dry mouldable drug formulation (2011-12-27),
4. 7666844 - Dry mouldable drug formulation (2010-02-23),
5. 6660197 - Method for producing an elongated drug formation (2003-12-09),
6. 6485453 - Cassette for storing and insertion of solid medicine (2002-11-26),
7. 6043214 - Method for producing powder formulation comprising an insulin (2000-03-28),
8. 5898028 - Method for producing powder formulation comprising an insulin (1999-04-27),
9. 5179079 - Nasal formulation and intranasal administration therewith (1993-01-12),
10. 4614730 - Stabilized insulin preparations and a process for preparation thereof (1986-09-30),

Title: The Innovations of Philip E. Hansen

Introduction

Philip E. Hansen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work focuses on improving the stability and efficacy of injectable pharmaceutical compositions.

Latest Patents

Among his latest patents is an invention titled "Injectable pharmaceutical compositions comprising adrenaline and citric acid." This invention relates to injectable pharmaceutical compositions that demonstrate improved storage stability, specifically those containing adrenaline and citric acid. Another notable patent is for a "Dry mouldable drug formulation," which consists of solid pharmaceutical compositions for parenteral injection. This formulation includes a binder and at least one therapeutic agent, allowing for direct injection without the need for cannulas or similar devices.

Career Highlights

Philip E. Hansen has worked with prominent companies in the pharmaceutical industry, including Novo Nordisk A/S and Novo Industri A/S. His experience in these organizations has contributed to his expertise in developing innovative drug formulations.

Collaborations

Throughout his career, Hansen has collaborated with esteemed colleagues such as Thomas Buch-Rasmussen and James M. Flink. These partnerships have further enhanced his contributions to the field of pharmaceuticals.

Conclusion

Philip E. Hansen's work in the pharmaceutical industry exemplifies innovation and dedication. His patents reflect a commitment to improving drug formulations and enhancing patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…